explore -WSS

explore

author：comprehensive 2025-08-18 11:33:10 - browse：11664

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Inside the fall of star MIT scientist David Sabatini

WSS

Bacterial infection may be ‘key event’ in endometriosis, study says

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

A new study asks: Are we harming blood donors by taking blood?

Van's Gluten Free Original Waffles recalled for possible wheat allergen

These geoengineering technologies could help combat the climate crisis, scientists say

Did the public have the right to know Arthur Ashe had AIDS?

explore

explore

focus

Continuity nursing helped my family in our darkest PICU moments

Stigma and the return of syphilis

Activists slam private health insurers over coverage restrictions

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

ChatGPT in medicine: STAT answers readers' burning questions

Startling documents reveal new facets of Sacklers' opioid empire

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

New air purifier tech could be key to improving indoor air quality

Report: NIH

focus

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Focused ultrasound for uterine fibroids: an uphill battle

Connecting traumatic brain injury and domestic violence

Community addresses injustice for Long Island mothers

Bacterial infection may be ‘key event’ in endometriosis, study says

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

hotspot

focus

focus

focus